Short-term Sintilimab in Combination With Taxane and Carboplatin for Neoadjuvant Therapy in Triple-negative Breast Cancer
Clinical trial NCT05843292 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05843292
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-01
- Primary completion
- 2024-12-31
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.